DNA binding ligands for Auger therapy and receptor imaging [ 2009 - 2012 ]

Also known as: Receptor-specifc cancer radiotherapy and diagnosis

Research Grant

[Cite as]

Researchers: Dr Tom Karagiannis (Principal investigator)

Brief description Our aim is to develop new technologies for very specific cancer radiotherapy and diagnostic imaging. The system involves the use of a protein linked to a radioactive DNA binding drug. The radioactivity we use has a very small range -a few millionths of a millimetre- allowing us to selectively kill cancer cells with minimal harm to healthy tissue. For diagnosis we use smaller amounts of radiation to obtain a clear image of the areas and extent of disease, which facilitates appropriate treatment.

Funding Amount $AUD 589,532.14

Funding Scheme NHMRC Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]